Extracellular matrix of intracerebral tumors with different invasion activity;Különbözo invazivitású agydaganatok extracelluláris mátrixának expressziója

Ideggyogyaszati Szemle

Volumn 63, Issue 1-2, 2010, Pages 38-43

  Klekner, Álmos ^a   Varga, Imre ^b   Bognár, László ^a   Hutóczki, Gábor ^a   Kenyeres, Annamária ^a   Tóth, Judit ^a   Hanzély, Zoltán ^c   Scholtz, Beáta ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Kenezy Korhaz Rendelointezet   (Hungary)

^c Orszagos Idegsebeszeti Tudomanyos Intezet Budapest   (Hungary)

Author keywords

Adenocarcinoma; Extracellular matrix; Glioblastoma; Invasion; Metastasis

Indexed keywords

BREVICAN; GELATINASE A; MESSENGER RNA; NEUROCAN; SYNDECAN 1; SYNDECAN 2; SYNDECAN 4; TENASCIN; VERSICAN; GELATINASE B; LECTIN; NCAN PROTEIN, HUMAN; NERVE PROTEIN; NEU DIFFERENTIATION FACTOR; NEUROGLYCAN C, HUMAN; PROTEOCHONDROITIN SULFATE; SYNDECAN; TUMOR MARKER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN CANCER; BRAIN METASTASIS; BRAIN SURGERY; BRAIN TUMOR; CANCER INFILTRATION; CANCER INVASION; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MELANOMA; NEUROSURGERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; ADENOCARCINOMA; AGED; CHEMISTRY; FEMALE; GENETICS; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; BRAIN NEOPLASMS; EXTRACELLULAR MATRIX; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; NEUREGULINS; POLYMERASE CHAIN REACTION; PROTEOCHONDROITIN SULFATES; RNA, MESSENGER; SYNDECANS; TENASCIN; TUMOR MARKERS, BIOLOGICAL; VERSICANS;

EID: 77952471121     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Yee AJM, Akens M, Yang BL et al. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Research 2007;9:R47.
2. Burger PC, Scheithauer BW. Tumors of the central nervous system. Atlas of Tumor Pathology, third series, fascicle 1994;10:349-69.
3. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 2007;114:97-109. (Pubitemid 47103521)
4. Bellail AC, Hunter SB, Brat DJ, et al. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004;36:1046-69. (Pubitemid 38501557)
5. Czirok A, Zamir EA, Filla MB, et al. Extracellular matrix macroassembly dynamics in early vertebrate embryos. Curr Top Dev Biol 2006;73:237-58. (Pubitemid 43878135)
6. Gladson CL. The extracellular matrix of gliomas: Modulation of cell function. J Neuropath Exp Neurol 1999;58: 1029-40. (Pubitemid 29468264)
7. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T). Method Methods 2001;25:402-8. (Pubitemid 34164012)
8. Han S, Sidell N, Roman J. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett 2005;219:71-81. (Pubitemid 40203173)
9. Hirose J, Kawashima H, Yoshie O, et al. Versican interacts with chemokines and modulates cellular responses. J Biol Chem 2001;276:5228-34.
10. Sainte-Marie G. A paraffin embedding technique for studies employing immunofluorescence. J Histochem Cytochem 1962;10:250-56.
11. Tuckett F, Morriss-Kay G. Alcian blue staining of glycosaminoglycans in embryonic material: effect of different fixatives. Histochem J 1988;20:174-82.
12. Jung S, Moon KS, Kim ST, et al. Increased expression of intracystic matrix metalloproteinases in brain tumors: relationship to the pathogenesis of brain tumor-associated cysts and peritumoral edema. J Clin Neurosci 2007;14:1192-8. (Pubitemid 350102780)
13. Leivonen M, Lundin J, Nordling S, et al. Prognostic value of syndecan-1 expression in breast cancer. Oncology 2004;67:11-8. (Pubitemid 39370345)
14. Pakula R, Melchior A, Denys A, et al. Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and Chemotaxis. Glycobiology 2007;17: 492-503. (Pubitemid 47049937)
15. Shibata SH, Fukada K, Suzuki SH, et al. Histochemical localisation of versican, aggrecan and hyaluronan in the developing condylar cartilage of the fetal rat mandible. Journal of Anatomy 2001;198:129-35. (Pubitemid 32177976)
16. Gary SC, Hockfield S. BEHAB/brevican: an extracellular matrix component associated with invasive glioma. Clin Neurosurg 2000;47:72-82.
17. Viapiano MS, Hockfield S, Matthews RT. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J Neurooncol 2008;88:261-72.
18. Mahesparan R, Read TA, Lund-Johansen M, et al. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 2003;105: 49-57. (Pubitemid 36798016)
19. Tews DS. Adhesive and invasive features in gliomas. Pathol Res Pract 2000;196:701-11.
20. Guo P, Imanishi Y, Cackowski FC, et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol 2005;166:877-90. (Pubitemid 40315644)
21. Watanabe A. Expression of syndecans, a heparan sulfate PG, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression. J Neurooncol 2006;77:25-33.
22. Higuchi M, Ohnishi T, Arita N, et al. Expression of tenascin in human gliomas: Its realation to histological malignancy. Acta Neuopath (Berlin) 1993;85:481-7. (Pubitemid 23180409)
23. Zagzag D, Friedlander DR, Dosik J, et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 1996;56:182-9. (Pubitemid 26010398)
24. Paulus W. Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol 1996;55:528-33. (Pubitemid 26140835)
25. Arnold SM. Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res 1999;5:4028-33. (Pubitemid 30013780)
26. Sunami E, Tsuno A, Osada T, et al. MMP-1 is a Prognostic Marker for Hematogenous Metastasis of Colorectal Cancer. The Oncologist 2000;5:108-14. (Pubitemid 30238230)
27. Zinzindohoué F, Lecomte Th, Ferraz J-M, et al. Prognostic Significance of MMP-1 and MMP-3 Functional Promoter Polymorphisms in Colorectal Cancer. Clinical Cancer Research 2005;11:594-9. (Pubitemid 40116884)
28. Khan ZA, Caurtero J, Barbin YP, et al. ED-B fibronectin in non-small cell lung carcinoma. Exp Lung Res 2005;31: 701-11. (Pubitemid 41359310)
29. Niki T, Kohno T, Iba S, et al. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am J Pathol 2002;160: 1129-41. (Pubitemid 34224599)
30. Szelachowska J, Jelen M, Kornafel J. Prognostic significance of intracellular laminin and Her2/neu overexpression in non-small cell lung cancer. Anticancer Res 2006;26:3871-6. (Pubitemid 44701474)
31. Pinnen R, Leinonen T, Bohm J, et al. Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. Hum Pathol 2005;36:44-50. (Pubitemid 40220332)
32. Fears CY. Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. J Biol Chem 2006;281:14533-6. (Pubitemid 43855155)